BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10627644)

  • 1. Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature.
    Lonial S; Bilodeau PA; Langston AA; Lewis C; Mossavi-Sai S; Holden JT; Waller EK
    Bone Marrow Transplant; 1999 Dec; 24(12):1337-41. PubMed ID: 10627644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature.
    Manoharan A; Williams NT; Sparrow R
    Q J Med; 1989 Mar; 70(263):243-52. PubMed ID: 2690174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.
    Yeşilipek ; Hazar V; Küpesiz A; Yegin O
    Bone Marrow Transplant; 2000 Sep; 26(5):571-2. PubMed ID: 11019849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated bone marrow transplant for congenital amegakaryocytic thrombocytopenia: report of two cases and review of the literature.
    Frangoul H; Keates-Baleeiro J; Calder C; Manes B; Crossno C; Castaneda VL; Domm J
    Pediatr Transplant; 2010 Jun; 14(4):E42-5. PubMed ID: 19490489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia.
    MacMillan ML; Davies SM; Wagner JE; Ramsay NK
    Bone Marrow Transplant; 1998 Apr; 21(7):735-7. PubMed ID: 9578317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT).
    Al-Ahmari A; Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; El-Solh H
    Bone Marrow Transplant; 2004 Apr; 33(8):829-31. PubMed ID: 14968137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
    Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
    Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor.
    Muraoka K; Ishii E; Ihara K; Imayoshi M; Miyazaki S; Hara T; Hamasaki Y
    Pediatr Transplant; 2005 Feb; 9(1):101-3. PubMed ID: 15667621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital amegakaryocytic thrombocytopenia: indication for allogeneic stem cell transplantation].
    de Vries DS; Bruin MC; Bierings M; Révész T
    Ned Tijdschr Geneeskd; 2000 Aug; 144(33):1596-8. PubMed ID: 10965369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia.
    Henter JI; Winiarski J; Ljungman P; Ringdén O; Ost A
    Bone Marrow Transplant; 1995 May; 15(5):799-801. PubMed ID: 7670411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation.
    Müller BU; Tichelli A; Passweg JR; Nissen C; Wodnar-Filipowicz A; Gratwohl A
    Bone Marrow Transplant; 1999 Jun; 23(11):1205-7. PubMed ID: 10382963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Au WY; Lie AK; Siu LL; Chan EC; Ooi GC; Leung AY; Liang R; Kwong YL
    Ann Hematol; 2003 Sep; 82(9):548-51. PubMed ID: 14504811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.
    Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K
    Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.
    Juvonen E; Aalto SM; Tarkkanen J; Volin L; Mattila PS; Knuutila S; Ruutu T; Hedman K
    Bone Marrow Transplant; 2003 Jul; 32(1):97-102. PubMed ID: 12815484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.